---
layout: minimal-medicine
title: Somapacitan
---

# Somapacitan
### Generic Name
Somapacitan

### Usage
Somapacitan is a growth hormone analog used primarily to replace the body's natural growth hormone in adults diagnosed with growth hormone deficiency.  This deficiency can stem from various causes, including genetic conditions, brain tumors, or prior treatments that damaged the pituitary gland (the area of the brain responsible for growth hormone production).  Currently, there is no established use in children.

### Dosage
**Adults (Growth Hormone Deficiency):** Somapacitan is administered subcutaneously (under the skin).  The initial dose is typically 1.5 mg once weekly.  The dose may be increased by 0.5-1.5 mg per week every 2-4 weeks, depending on the patient's response (monitored through IGF-1 levels and clinical improvement) and tolerance.  The maximum recommended dose is 8 mg per week.  Treatment should be considered if no benefits are seen after 12-18 months.  If benefits are observed, treatment may continue indefinitely.  Dosage adjustments are necessary for patients with hepatic (liver) impairment.  Those with mild impairment may not require dosage changes, but moderate impairment might necessitate starting with 1 mg weekly and adjusting in smaller increments (maximum 4 mg/week). Severe hepatic impairment contraindicates the use of Somapacitan. Renal (kidney) impairment does not have specific dosage adjustments outlined in current guidelines; however, drug exposure increases with decreased kidney function.

**Children:** The safety and effectiveness of Somapacitan have not been established in children.

**Administration:** Somapacitan is usually injected into the abdomen or thigh. Injection sites should be rotated weekly to prevent lipohypertrophy (excess fat buildup) or lipoatrophy (loss of fat).

### Side Effects
**Common Side Effects (>10%):**

* Increased serum phosphate levels.

**Less Common Side Effects (1-10%):**

* Dizziness
* Sleep disorders
* Hypertension (high blood pressure)
* Peripheral edema (swelling in the extremities)
* Dyspepsia (indigestion)
* Vomiting
* Adrenocortical insufficiency (reduced adrenal gland function)
* Weight gain
* Anemia
* Arthralgia (joint pain)
* Back pain
* Increased creatine phosphokinase levels (a muscle enzyme)
* Tonsillitis

**Rare Side Effects (Frequency not defined):**

* Lipoatrophy (loss of subcutaneous fat at the injection site)
* Lipohypertrophy (excess fat buildup at the injection site)

**Serious Side Effects (Less Common but Require Immediate Medical Attention):**  Malignancy progression, papilledema (swelling of the optic nerve), serious hypersensitivity reactions (including anaphylaxis),  and worsening of pre-existing conditions such as diabetes or hypoadrenalism.

Always consult a healthcare professional if you experience any concerning side effects.


### How it Works
Somapacitan is a modified version of human growth hormone. It binds to growth hormone receptors on cells, triggering various effects. Some effects are indirect, mediated by insulin-like growth factor 1 (IGF-1) produced in the liver in response to Somapacitan.  Other effects are direct results of Somapacitan binding to its receptor.  This leads to improved growth, metabolism, and other physiological processes affected by growth hormone deficiency.


### Precautions
**Contraindications:** Somapacitan is contraindicated (should not be used) in patients with hypersensitivity to Somapacitan or its components, acute critical illnesses (such as after major surgery or trauma), active malignancy, and active proliferative or severe non-proliferative diabetic retinopathy.

**Drug Interactions:**  Somapacitan may interact with glucocorticoids (requiring dose adjustments), oral estrogens (potentially necessitating higher Somapacitan doses), and insulin or other hypoglycemic agents (due to potential decreased insulin sensitivity).  It may also alter the metabolism of other drugs processed by the cytochrome P450 system.

**Specific Populations:**  Older adults may be more sensitive to Somapacitan.  Pregnant and breastfeeding women should consult with their healthcare provider due to the lack of data on Somapacitan's safety during pregnancy and breastfeeding.

**Warnings:** Somapacitan increases the risk of malignancy progression, glucose intolerance, diabetes mellitus, intracranial hypertension, serious hypersensitivity reactions, fluid retention, hypoadrenalism, hypothyroidism, pancreatitis, and lipohypertrophy/lipoatrophy. Regular monitoring is crucial.

### FAQs

* **Q: How is Somapacitan stored?** A:  Storage instructions should be found on the product label, but generally, it needs to be refrigerated.

* **Q: How long does it take to see results?** A: The time to see benefits varies, but regular monitoring of IGF-1 levels and clinical assessments will guide treatment adjustments. Improvement may take several months.

* **Q: What should I do if I miss a dose?** A: Administer the missed dose as soon as possible within 3 days; then resume your regular schedule. If it has been more than 3 days, skip the missed dose and administer the next dose on the scheduled day.

* **Q: Can I share my Somapacitan pen with another person?** A: No, this is unsafe and increases the risk of infection.  Each pen should be used by only one person.


**Disclaimer:** This information is for general knowledge and does not constitute medical advice. Always consult a healthcare professional for diagnosis and treatment of any medical condition.  This information is based on currently available data and may be subject to change. Always refer to the most up-to-date prescribing information for complete details.
